Make your own free website on Tripod.com
©2010, Lividus Pharmaceuticals, All Rights Reserved
Layout
Manufacturing:

    Our manufacturing processes are designed to be lean, fast and scaleable in order to fulfil the mission of ensuring product availability of the highest quality on time and at a competitive price to our internal and external customers. Lividus manufacture products for any clients in the world over. Our success is based on a customer-tailored approach and quality standards aligned with regulatory authorities in the world. We provide lifecycle support that includes clinical development, product launch, packaging, process optimisation and formulation.

Technologies:

     Lividus offers a wide range of technologies, production and packaging of solid, semi-solid and liquid pharmaceuticals as well as steriles and non-steriles manufacturing. We have the right technology and expertise for producing solids, from clinical to bulk production. Lividus manufacture semi-solid pharmaceutical products in a variety of dosage forms and produce liquids that meet strict standards set by regulatory authorities. We offer a range of steriles, from ampoules, vials, syringes to cartridges. Our manufacturing facilities operate in strict compliance with current good manufacturing practices. In addition to the inspections by the regulatory authorities, our facilities are subjected to regular inspections from corporate auditors, ensuring a continuous improvement and a high level of current good manufacturing practices.

Marketing is redefined with
informative and innovative
professionals with people
focus
Bulk Drug Manufacturing
industry made itsstunning
heights with Lividus
pharma..
+91 - 4761234567
News and Events



  • ClinTec International, Global CRO, ranked in Deloitte UK Technology Fast 50 & Fast 500 EMEA League of fast growing technology companies.

  • Cell Biologist Joins Adult Stem Cell Research Company, TCA Cellular Therapy

  • TriPoint Global Research Announces Investment Opinion on China Pharmaceuticals, Inc.

  • Pfizer CEO change could signal strategic switch

  • Credit Suisse shuffles pharma-sector ratings

  • Healthcare Reform: Overcoming Hurdles and Building Up Successes

  • AUXILIO signs long-term Managed Print Services contracts with St. Joseph Health System hospitals in Sonoma and Napa counties, CA

  • New Survey of Breast Cancer Patients Shows That Women Taking Tamoxifen Want a CYP2D6 Genetic Test

  • Apricus Biosciences Launches Educational Video Series Focused On Its Newly Approved Erectile Dysfunction Drug, Vitaros®

  • Hemolysis Is Associated with Increased Mortality and Thrombosis in Patients with PNH

  • EHSI: Celulas Genetica Eyes China for Testing New Stem Cell Procedure

  • Operational Excellence for Pharmaceuticals, Biotech and Medical Devices

  • BIT's 2nd Annual International Congress of Cardiology

  • Winning in The New Competitive Pharma Market

  • Health Technology Assessment World Europe 2010

  • Innovation in Drug Discovery: Science & Technology

  • Innovation in Clinical Design: Analysis and Reporting

  • ClinTec International, Global CRO, ranked in Deloitte UK Technology Fast 50 & Fast 500 EMEA League of fast growing technology companies.

  • Cell Biologist Joins Adult Stem Cell Research Company, TCA Cellular Therapy

  • TriPoint Global Research Announces Investment Opinion on China Pharmaceuticals, Inc.

  • Pfizer CEO change could signal strategic switch

  • Credit Suisse shuffles pharma-sector ratings

  • Healthcare Reform: Overcoming Hurdles and Building Up Successes

  • AUXILIO signs long-term Managed Print Services contracts with St. Joseph Health System hospitals in Sonoma and Napa counties, CA

  • New Survey of Breast Cancer Patients Shows That Women Taking Tamoxifen Want a CYP2D6 Genetic Test

  • Apricus Biosciences Launches Educational Video Series Focused On Its Newly Approved Erectile Dysfunction Drug, Vitaros®

  • Hemolysis Is Associated with Increased Mortality and Thrombosis in Patients with PNH

  • EHSI: Celulas Genetica Eyes China for Testing New Stem Cell Procedure

  • Operational Excellence for Pharmaceuticals, Biotech and Medical Devices

  • BIT's 2nd Annual International Congress of Cardiology

  • Winning in The New Competitive Pharma Market

  • Health Technology Assessment World Europe 2010

  • Innovation in Drug Discovery: Science & Technology

  • Innovation in Clinical Design: Analysis and Reporting

Home  |  Manufacturing  |  Products  |  Careers  |  Contact